{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:48:32Z","timestamp":1794473312030,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Replacement of the <jats:italic>in vivo<\/jats:italic> rabies vaccine potency test (NIH test) by <jats:italic>in vitro<\/jats:italic> methods had been discussed by several researcher including WHO expert working groups. In this paper, a time-resolved fluoroimmunoassay (TRFIA) for the assay of rabies virus glycoprotein in rabies vaccine was first established to estimate the rabies vaccine potency by using specific monoclonal antibody that only recognized the native, trimeric and immunogenic form of rabies virus glycoprotein. Potency of the rabies virus glycoprotein was assayed with satisfactory performance under optimal conditions, and the method demonstrated satisfactory results when applied in practical samples. The correlation coefficient of potency values obtained from the present TRFIA and ELISA was 0.912, and 0.903 for those from the present TRFIA and NIH test. These preliminary results confirmed that this TRFIA can replace ELISA with higher performance, and could be a promising replacement of the NIH test. Based upon these results, the present TRFIA seemed to be a convenient tool for evaluating rabies vaccine potency and its products at different stages accordingly.<\/jats:p>","DOI":"10.1038\/s41598-017-07687-7","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T10:00:34Z","timestamp":1501495234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A time-resolved fluoroimmunoassay to assay the rabies virus glycoprotein: application for estimation of human rabies vaccine potency"],"prefix":"10.1038","volume":"7","author":[{"given":"Guanfeng","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoting","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongliang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiancai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingsong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"7687_CR1","doi-asserted-by":"crossref","unstructured":"Dodet, B. & Asian Rabies Expert, B. An important date in rabies history. Vaccine \n                           25, 8647\u20138650 (2007).","DOI":"10.1016\/j.vaccine.2007.10.004"},{"key":"7687_CR2","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1128\/CVI.00204-10","volume":"17","author":"SV Nimmagadda","year":"2010","unstructured":"Nimmagadda, S. V. et al. Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein. Clin. Vaccine Immunol. \n                           17, 1261\u20131268 (2010).","journal-title":"Clin. Vaccine Immunol."},{"key":"7687_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/biot.200600211","volume":"2","author":"AY Yokomizo","year":"2007","unstructured":"Yokomizo, A. Y. et al. Rabies virus glycoprotein expression in Drosophila S2 cells. I. Functional recombinant protein in stable co-transfected cell line. Biotechnology journal \n                           2, 102\u2013109 (2007).","journal-title":"Biotechnology journal"},{"key":"7687_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2460\/javma.246.2.205","volume":"246","author":"MC Moore","year":"2015","unstructured":"Moore, M. C. et al. Comparison of anamnestic responses to rabies vaccination in dogs and cats with current and out-of-date vaccination status. J Am Vet Med Assoc \n                           246, 205\u2013211 (2015).","journal-title":"J Am Vet Med Assoc"},{"key":"7687_CR5","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1016\/j.vaccine.2013.05.081","volume":"31","author":"TG Smith","year":"2013","unstructured":"Smith, T. G. et al. An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines. Vaccine \n                           31, 3333\u20133338 (2013).","journal-title":"Vaccine"},{"key":"7687_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1045-1056(05)80051-X","volume":"20","author":"J Lyng","year":"1992","unstructured":"Lyng, J., Bentzon, M. W., Ferguson, M. & Fitzgerald, E. A. Rabies vaccine standardization: International Collaborative Study for the Characterization of the fifth International Standard for Rabies Vaccine. Biologicals \n                           20, 301\u2013313 (1992).","journal-title":"Biologicals"},{"key":"7687_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","volume":"6","author":"R Barth","year":"1988","unstructured":"Barth, R., Diderrich, G. & Weinmann, E. NIH test, a problematic method for testing potency of inactivated rabies vaccine. Vaccine \n                           6, 369\u2013377 (1988).","journal-title":"Vaccine"},{"key":"7687_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/1045-1056(90)90037-Z","volume":"18","author":"P Perrin","year":"1990","unstructured":"Perrin, P., Morgeaux, S. & Sureau, P. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody. Biologicals \n                           18, 321\u2013330 (1990).","journal-title":"Biologicals"},{"issue":"Suppl 4","key":"7687_CR9","doi-asserted-by":"publisher","first-page":"S771","DOI":"10.1093\/clinids\/10.Supplement_4.S771","volume":"10","author":"WH Wunner","year":"1988","unstructured":"Wunner, W. H., Larson, J. K., Dietzschold, B. & Smith, C. L. The molecular biology of rabies viruses. Rev. Infect. Dis. \n                           10(Suppl 4), S771\u2013784 (1988).","journal-title":"Rev. Infect. Dis."},{"key":"7687_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.biologicals.2005.07.004","volume":"34","author":"T Nagarajan","year":"2006","unstructured":"Nagarajan, T. et al. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture. Biologicals \n                           34, 21\u201327 (2006).","journal-title":"Biologicals"},{"key":"7687_CR11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1045-1056(05)80062-4","volume":"20","author":"M Ferguson","year":"1992","unstructured":"Ferguson, M. & Heath, A. Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use. Biologicals \n                           20, 143\u2013154 (1992).","journal-title":"Biologicals"},{"key":"7687_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0092-1157(85)80042-1","volume":"13","author":"M Lafon","year":"1985","unstructured":"Lafon, M., Perrin, P., Versmisse, P. & Sureau, P. Use of a monoclonal antibody for quantitation of rabies vaccine glycoprotein by enzyme immunoassay. J. Biol. Stand. \n                           13, 295\u2013301 (1985).","journal-title":"J. Biol. Stand."},{"key":"7687_CR13","first-page":"73","volume":"64","author":"EA Fitzgerald","year":"1986","unstructured":"Fitzgerald, E. A. & Needy, C. F. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine. Dev. Biol. Stand. \n                           64, 73\u201379 (1986).","journal-title":"Dev. Biol. Stand."},{"key":"7687_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1099\/0022-1317-59-1-197","volume":"59","author":"M Ferguson","year":"1982","unstructured":"Ferguson, M. & Schild, G. C. A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies. J Gen Virol \n                           59, 197\u2013201 (1982).","journal-title":"J Gen Virol"},{"key":"7687_CR15","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0092-1157(89)80001-0","volume":"17","author":"O Thraenhart","year":"1989","unstructured":"Thraenhart, O. & Ramakrishnan, K. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera. J. Biol. Stand. \n                           17, 291\u2013309 (1989).","journal-title":"J. Biol. Stand."},{"key":"7687_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","volume":"31","author":"J Fournier-Caruana","year":"2003","unstructured":"Fournier-Caruana, J. et al. Inactivated rabies vaccine control and release: use of an ELISA method. Biologicals \n                           31, 9\u201316 (2003).","journal-title":"Biologicals"},{"key":"7687_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jviromet.2007.07.015","volume":"146","author":"M Mousli","year":"2007","unstructured":"Mousli, M., Turki, I., Kharmachi, H., Saadi, M. & Dellagi, K. Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture. J Virol Methods \n                           146, 246\u2013256 (2007).","journal-title":"J Virol Methods"},{"key":"7687_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/0039-9140(84)80220-9","volume":"31","author":"T Lovgren","year":"1984","unstructured":"Lovgren, T., Hemmila, I., Pettersson, K., Eskola, J. U. & Bertoft, E. Determination of hormones by time-resolved fluoroimmunoassay. Talanta \n                           31, 909\u2013916 (1984).","journal-title":"Talanta"},{"key":"7687_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0163-7258(94)00078-H","volume":"66","author":"EF Dickson","year":"1995","unstructured":"Dickson, E. F., Pollak, A. & Diamandis, E. P. Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol. Ther. \n                           66, 207\u2013235 (1995).","journal-title":"Pharmacol. Ther."},{"key":"7687_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/clinchem\/31.3.359","volume":"31","author":"I Hemmila","year":"1985","unstructured":"Hemmila, I. Fluoroimmunoassays and immunofluorometric assays. Clin Chem \n                           31, 359\u2013370 (1985).","journal-title":"Clin Chem"},{"key":"7687_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0003-2697(84)90095-2","volume":"137","author":"I Hemmila","year":"1984","unstructured":"Hemmila, I., Dakubu, S., Mukkala, V. M., Siitari, H. & Lovgren, T. Europium as a label in time-resolved immunofluorometric assays. Anal Biochem \n                           137, 335\u2013343 (1984).","journal-title":"Anal Biochem"},{"key":"7687_CR22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/clinchem\/40.3.347","volume":"40","author":"LJ Kricka","year":"1994","unstructured":"Kricka, L. J. Selected strategies for improving sensitivity and reliability of immunoassays. Clin Chem \n                           40, 347\u2013357 (1994).","journal-title":"Clin Chem"},{"key":"7687_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/bio.2396","volume":"28","author":"GF Lin","year":"2013","unstructured":"Lin, G. F., Liu, T. C., Zou, L. P., Hou, J. Y. & Wu, Y. S. Development of a dual-label time-resolved fluoroimmunoassay for the detection of alpha-fetoprotein and hepatitis B virus surface antigen. Luminescence \n                           28, 401\u2013406 (2013).","journal-title":"Luminescence"},{"key":"7687_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jviromet.2014.06.002","volume":"206","author":"G Lin","year":"2014","unstructured":"Lin, G. et al. A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine. J Virol Methods \n                           206, 89\u201394 (2014).","journal-title":"J Virol Methods"},{"key":"7687_CR25","doi-asserted-by":"publisher","first-page":"55229","DOI":"10.1039\/C4RA09848J","volume":"4","author":"GF Lin","year":"2015","unstructured":"Lin, G. F. et al. Simultaneous determination of the cytokeratin 19 fragment and carcinoembryonic antigen in human serum by magnetic nanoparticle-based dual-label time-resolved fluoroimmunoassay. RSC Adv \n                           4, 55229\u201355236 (2015).","journal-title":"RSC Adv"},{"key":"7687_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jim.2016.08.006","volume":"437","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Rapid quantitation of human epididymis protein 4 in human serum by amplified luminescent proximity homogeneous immunoassay (AlphaLISA). J Immunol Methods \n                           437, 64\u201369 (2016).","journal-title":"J Immunol Methods"},{"key":"7687_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.aca.2012.10.060","volume":"758","author":"X Pei","year":"2013","unstructured":"Pei, X. et al. Sandwich-type immunosensors and immunoassays exploiting nanostructure labels: A review. Anal Chim Acta \n                           758, 1\u201318 (2013).","journal-title":"Anal Chim Acta"},{"key":"7687_CR28","doi-asserted-by":"crossref","unstructured":"Howard, G. C. & Kaser, M. R. Making and Using Antibodies. Taylor & Francis Group, LLC. (2007).","DOI":"10.1201\/9781420005196"},{"key":"7687_CR29","unstructured":"Seligmann, E. B. Jr. Laboratory techniques in rabies: the NIH test for potency. Monograph series. World Health Organization, 279\u2013286 (1973)."},{"key":"7687_CR30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.biologicals.2009.01.001","volume":"37","author":"B Kramer","year":"2009","unstructured":"Kramer, B., Schildger, H., Behrensdorf-Nicol, H. A., Hanschmann, K. M. & Duchow, K. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines. Biologicals \n                           37, 119\u2013126 (2009).","journal-title":"Biologicals"},{"key":"7687_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/clinchem\/29.1.65","volume":"29","author":"E Soini","year":"1983","unstructured":"Soini, E. & Kojola, H. Time-resolved fluorometer for lanthanide chelates\u2013a new generation of nonisotopic immunoassays. Clin Chem \n                           29, 65\u201368 (1983).","journal-title":"Clin Chem"},{"key":"7687_CR32","first-page":"98","volume":"25","author":"XJ Lv","year":"2012","unstructured":"Lv, X. J. et al. Preparation and initial application of a monoclonal antibody specific for a newly discovered conserved linear epitope of rabies virus nucleoprotein. Biomed. Environ. Sci. \n                           25, 98\u2013103 (2012).","journal-title":"Biomed. Environ. Sci."},{"key":"7687_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jviromet.2006.08.006","volume":"138","author":"Y He","year":"2006","unstructured":"He, Y., Gao, D. & Zhang, M. Expression of the nucleoprotein gene of rabies virus for use as a diagnostic reagent. J. Virol. Methods \n                           138, 147\u2013151 (2006).","journal-title":"J. Virol. Methods"},{"issue":"Pt 8","key":"7687_CR34","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1099\/0022-1317-64-8-1649","volume":"64","author":"WH Wunner","year":"1983","unstructured":"Wunner, W. H., Dietzschold, B., Curtis, P. J. & Wiktor, T. J. Rabies subunit vaccines. J Gen Virol \n                           64(Pt 8), 1649\u20131656 (1983).","journal-title":"J Gen Virol"},{"key":"7687_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.aca.2012.04.044","volume":"734","author":"JY Hou","year":"2012","unstructured":"Hou, J. Y. et al. Development of an immunomagnetic bead-based time-resolved fluorescence immunoassay for rapid determination of levels of carcinoembryonic antigen in human serum. Anal Chim Acta \n                           734, 93\u201398 (2012).","journal-title":"Anal Chim Acta"},{"key":"7687_CR36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10895-015-1518-0","volume":"25","author":"G Lin","year":"2015","unstructured":"Lin, G. et al. A magnetic nanoparticle-based time-resolved fluoroimmunoassay for determination of the cytokeratin 19 fragment in human serum. J Fluoresc \n                           25, 361\u2013367 (2015).","journal-title":"J Fluoresc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07687-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T07:59:56Z","timestamp":1671782396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-07687-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["7687"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-07687-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]},"assertion":[{"value":"17 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"7288"}}